Hepatitis C virus genotyping based on Core and NS5B regions in Cameroonian patients

Abstract Background Current HCV treatments are genotype specific although potential pan-genotype treatments have recently been described. Therefore, genotyping is an essential tool for the therapeutic management of HCV infection and a variety of technologies have been developed for HCV genotypes det...

Full description

Bibliographic Details
Main Authors: Paul Alain Tagnouokam-Ngoupo, Marie Nicole Ngoufack, Sebastien Kenmoe, Simon Frédéric Lissock, Marie Amougou-Atsama, Robert Banai, Laure Ngono, Richard Njouom
Format: Article
Language:English
Published: BMC 2019-08-01
Series:Virology Journal
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12985-019-1214-9
_version_ 1818508963399860224
author Paul Alain Tagnouokam-Ngoupo
Marie Nicole Ngoufack
Sebastien Kenmoe
Simon Frédéric Lissock
Marie Amougou-Atsama
Robert Banai
Laure Ngono
Richard Njouom
author_facet Paul Alain Tagnouokam-Ngoupo
Marie Nicole Ngoufack
Sebastien Kenmoe
Simon Frédéric Lissock
Marie Amougou-Atsama
Robert Banai
Laure Ngono
Richard Njouom
author_sort Paul Alain Tagnouokam-Ngoupo
collection DOAJ
description Abstract Background Current HCV treatments are genotype specific although potential pan-genotype treatments have recently been described. Therefore, genotyping is an essential tool for the therapeutic management of HCV infection and a variety of technologies have been developed for HCV genotypes determination. Sequences analysis of HCV sub-genomic regions is considered as gold standard and is widely used for HCV genotyping. Here, we compared HCV genotyping using core and NS5B regions in routine practice in HCV-positive Cameroonian patients. Methods All plasma samples received at Centre Pasteur of Cameroon (CPC) in 2016 for HCV genotyping were included. Viral loads were determined using the Abbott Real Time assay. Further, genotyping was based on the amplification and sequencing of core and NS5B regions following by phylogenetic analysis of corresponding sequences. Results A total of 369 samples were received during the study period with high viral load values (median: 930,952 IU/ml; IQR: 281,833-2,861,179). Positive amplification was obtained in at least one genomic region (core or NS5B) for all the samples with similar amplification rate in the two genomic regions (p = 0.34). Phylogenetic analysis showed that among the 369 samples, 146 (39.6%) were classified as genotype 4, 132 (35.8%) as genotype 1, 89 (24.1%) as genotype 2, in both core and NS5B regions. Interestingly, for two samples (0.54%) discordant genotypes were obtained in both regions with the core region classified as genotype 4 while the NS5B was identified as genotype 1 indicating the presence of putative HCV recombinant virus or multiple infections in these samples. Discrimination of HCV subtypes was most likely possible with NS5B compared to core region. Conclusions We found high amplification rates of HCV in both core and NS5B regions, and a good concordance was obtained at genotype level using both regions except for two samples where putative 1–4 recombinants/multiple infections were detected. Therefore, HCV genotyping based on at least two genomic regions could help to identify putative recombinants and improve therapeutic management of HCV infection.
first_indexed 2024-12-10T22:39:04Z
format Article
id doaj.art-edd3091ffcb944c2b1c42feba3cd6158
institution Directory Open Access Journal
issn 1743-422X
language English
last_indexed 2024-12-10T22:39:04Z
publishDate 2019-08-01
publisher BMC
record_format Article
series Virology Journal
spelling doaj.art-edd3091ffcb944c2b1c42feba3cd61582022-12-22T01:30:45ZengBMCVirology Journal1743-422X2019-08-011611710.1186/s12985-019-1214-9Hepatitis C virus genotyping based on Core and NS5B regions in Cameroonian patientsPaul Alain Tagnouokam-Ngoupo0Marie Nicole Ngoufack1Sebastien Kenmoe2Simon Frédéric Lissock3Marie Amougou-Atsama4Robert Banai5Laure Ngono6Richard Njouom7Virology Department, Centre Pasteur of CameroonVirology Department, Centre Pasteur of CameroonVirology Department, Centre Pasteur of CameroonVirology Department, Centre Pasteur of CameroonVirology Department, Centre Pasteur of CameroonVirology Department, Centre Pasteur of CameroonVirology Department, Centre Pasteur of CameroonVirology Department, Centre Pasteur of CameroonAbstract Background Current HCV treatments are genotype specific although potential pan-genotype treatments have recently been described. Therefore, genotyping is an essential tool for the therapeutic management of HCV infection and a variety of technologies have been developed for HCV genotypes determination. Sequences analysis of HCV sub-genomic regions is considered as gold standard and is widely used for HCV genotyping. Here, we compared HCV genotyping using core and NS5B regions in routine practice in HCV-positive Cameroonian patients. Methods All plasma samples received at Centre Pasteur of Cameroon (CPC) in 2016 for HCV genotyping were included. Viral loads were determined using the Abbott Real Time assay. Further, genotyping was based on the amplification and sequencing of core and NS5B regions following by phylogenetic analysis of corresponding sequences. Results A total of 369 samples were received during the study period with high viral load values (median: 930,952 IU/ml; IQR: 281,833-2,861,179). Positive amplification was obtained in at least one genomic region (core or NS5B) for all the samples with similar amplification rate in the two genomic regions (p = 0.34). Phylogenetic analysis showed that among the 369 samples, 146 (39.6%) were classified as genotype 4, 132 (35.8%) as genotype 1, 89 (24.1%) as genotype 2, in both core and NS5B regions. Interestingly, for two samples (0.54%) discordant genotypes were obtained in both regions with the core region classified as genotype 4 while the NS5B was identified as genotype 1 indicating the presence of putative HCV recombinant virus or multiple infections in these samples. Discrimination of HCV subtypes was most likely possible with NS5B compared to core region. Conclusions We found high amplification rates of HCV in both core and NS5B regions, and a good concordance was obtained at genotype level using both regions except for two samples where putative 1–4 recombinants/multiple infections were detected. Therefore, HCV genotyping based on at least two genomic regions could help to identify putative recombinants and improve therapeutic management of HCV infection.http://link.springer.com/article/10.1186/s12985-019-1214-9HCVGenotypingCoreNS5BGenotypesSubtypes
spellingShingle Paul Alain Tagnouokam-Ngoupo
Marie Nicole Ngoufack
Sebastien Kenmoe
Simon Frédéric Lissock
Marie Amougou-Atsama
Robert Banai
Laure Ngono
Richard Njouom
Hepatitis C virus genotyping based on Core and NS5B regions in Cameroonian patients
Virology Journal
HCV
Genotyping
Core
NS5B
Genotypes
Subtypes
title Hepatitis C virus genotyping based on Core and NS5B regions in Cameroonian patients
title_full Hepatitis C virus genotyping based on Core and NS5B regions in Cameroonian patients
title_fullStr Hepatitis C virus genotyping based on Core and NS5B regions in Cameroonian patients
title_full_unstemmed Hepatitis C virus genotyping based on Core and NS5B regions in Cameroonian patients
title_short Hepatitis C virus genotyping based on Core and NS5B regions in Cameroonian patients
title_sort hepatitis c virus genotyping based on core and ns5b regions in cameroonian patients
topic HCV
Genotyping
Core
NS5B
Genotypes
Subtypes
url http://link.springer.com/article/10.1186/s12985-019-1214-9
work_keys_str_mv AT paulalaintagnouokamngoupo hepatitiscvirusgenotypingbasedoncoreandns5bregionsincameroonianpatients
AT marienicolengoufack hepatitiscvirusgenotypingbasedoncoreandns5bregionsincameroonianpatients
AT sebastienkenmoe hepatitiscvirusgenotypingbasedoncoreandns5bregionsincameroonianpatients
AT simonfredericlissock hepatitiscvirusgenotypingbasedoncoreandns5bregionsincameroonianpatients
AT marieamougouatsama hepatitiscvirusgenotypingbasedoncoreandns5bregionsincameroonianpatients
AT robertbanai hepatitiscvirusgenotypingbasedoncoreandns5bregionsincameroonianpatients
AT laurengono hepatitiscvirusgenotypingbasedoncoreandns5bregionsincameroonianpatients
AT richardnjouom hepatitiscvirusgenotypingbasedoncoreandns5bregionsincameroonianpatients